393 related articles for article (PubMed ID: 14655006)
21. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
[TBL] [Abstract][Full Text] [Related]
22. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.
Korpela M; Laasonen L; Hannonen P; Kautiainen H; Leirisalo-Repo M; Hakala M; Paimela L; Blåfield H; Puolakka K; Möttönen T;
Arthritis Rheum; 2004 Jul; 50(7):2072-81. PubMed ID: 15248204
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of rheumatoid arthritis].
Bolten WW
MMW Fortschr Med; 2008 Aug; 150(32-35):50-3; quiz 54. PubMed ID: 19006884
[No Abstract] [Full Text] [Related]
24. Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score.
van der Kooij SM; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; van Zeben D; Kerstens PJ; Gerards AH; van Groenendael JH; Hazes JM; Breedveld FC; Allaart CF; Dijkmans BA
Ann Rheum Dis; 2007 Oct; 66(10):1356-62. PubMed ID: 17293364
[TBL] [Abstract][Full Text] [Related]
25. [Long-term drug treatment of chronic polyarthritis: current status and perspectives].
Wollenhaupt J; Langer HE
Wien Med Wochenschr; 1990 Jun; 140(12):324-33. PubMed ID: 2204217
[TBL] [Abstract][Full Text] [Related]
26. Treatment of rheumatoid arthritis (RA) in India-how and by whom: results from a speciality clinic-use of low-dose methotrexate (MTX) was inexplicably suboptimal.
Malaviya AN; Gogia SB
Clin Rheumatol; 2016 Sep; 35(9):2163-73. PubMed ID: 27122121
[TBL] [Abstract][Full Text] [Related]
27. [Therapy of rheumatoid arthritis (chronic polyarthritis)].
Villiger PM; Stucki G
Praxis (Bern 1994); 1996 Sep; 85(37):1102-7. PubMed ID: 8927885
[TBL] [Abstract][Full Text] [Related]
28. [Armentarium and strategies for the treatment of rheumatoid arthritis].
Lioté F
Rev Prat; 2005 Dec; 55(19):2146-60. PubMed ID: 16544925
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis.
Castrejón I; Gibson KA; Pincus T
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S20-8. PubMed ID: 24219037
[TBL] [Abstract][Full Text] [Related]
30. Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience.
Nordström DC; Konttinen L; Korpela M; Tiippana-Kinnunen T; Eklund K; Forsberg S; Ilva K; Kaipiainen-Seppänen O; Malmi T; Ylä-Kerttula T; Honkanen V
Rheumatol Int; 2006 Jun; 26(8):741-8. PubMed ID: 16205925
[TBL] [Abstract][Full Text] [Related]
31. Therapy of rheumatoid arthritis: new developments and trends.
St Clair EW
Curr Rheumatol Rep; 1999 Dec; 1(2):149-56. PubMed ID: 11123029
[TBL] [Abstract][Full Text] [Related]
32. Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapy.
Wabe N; Wojciechowski J; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Proudman S; Wiese MD
Int J Rheum Dis; 2017 Oct; 20(10):1447-1456. PubMed ID: 28952204
[TBL] [Abstract][Full Text] [Related]
33. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
[TBL] [Abstract][Full Text] [Related]
34. Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden.
Kristensen LE; Saxne T; Nilsson JA; Geborek P
Arthritis Res Ther; 2006; 8(6):R174. PubMed ID: 17121678
[TBL] [Abstract][Full Text] [Related]
35. Disease-modifying anti-rheumatic drug therapy and structural damage in early rheumatoid arthritis.
Mullan RH; Bresnihan B
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S158-64. PubMed ID: 14969069
[TBL] [Abstract][Full Text] [Related]
36. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I
Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
[TBL] [Abstract][Full Text] [Related]
37. Disease modification in rheumatoid arthritis with leflunomide.
Emery P
Scand J Rheumatol Suppl; 1999; 112():9-14. PubMed ID: 10668522
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs.
Dale J; Alcorn N; Capell H; Madhok R
Nat Clin Pract Rheumatol; 2007 Aug; 3(8):450-8; quiz, following 478. PubMed ID: 17664952
[TBL] [Abstract][Full Text] [Related]
39. [Disease-modifying treatment for inflammatory rheumatism in sub-Saharan Africa: outcome at 6 months of 205 Senegalese patients with rheumatoid arthritis].
Ndongo S; Pouye A; Lekpa FK; Bihéhé DM; Tiendrebeogo J; Ndao AC; Ka MM; Moreira Diop T
Med Sante Trop; 2012; 22(4):385-9. PubMed ID: 23352953
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions.
Bays AM; Gardner G
Med Clin North Am; 2016 Jul; 100(4):719-31. PubMed ID: 27235612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]